Nurse Practitioner, Family · Auburn, CA
NPI
1932532272
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
11795 Education St Ste 213
Auburn, CA, 95602
Phone (530) 886-6800
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
963 services
Medicare patients, 2024
645
Average age 75
Drug cost, 2024
$743K
2,437 prescriptions
Company payments, 2025
$633
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Svetlana R Mulcahy was code 99214 (office e&m - established), 528 times for 355 patients. In total Svetlana R Mulcahy billed 963 services in 5 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 528 | 355 | $81.90 | $43K |
| 99204 Office E&M - New | Office | 191 | 191 | $102.65 | $20K |
| 99213 Office E&M - Established | Office | 141 | 125 | $55.67 | $7,850 |
| 99203 Office E&M - New | Office | 101 | 101 | $63.95 | $6,459 |
By year: 2022 $78K for 895 services; 2023 $74K for 907 services; 2024 $77K for 963 services.
Medicare prescription drug claims, 2024
In 2024, the drug Svetlana R Mulcahy prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 589 prescriptions and refills. In total Svetlana R Mulcahy wrote 2,437 Medicare prescriptions that cost $743K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 589 | 589 | 579 | $38K |
| Pantoprazole Sodium Generic | 554 | 1,099 | 178 | $6,477 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 454 | 454 | 443 | $7,383 |
| Omeprazole Generic | 311 | 590 | 98 | $3,666 |
| Zenpep Lipase/Protease/Amylase | 87 | 119 | 17 | $410K |
| Famotidine Generic | 65 | 157 | 24 | $1,157 |
| Linzess Linaclotide | 60 | 60 | 13 | $31K |
| Creon Lipase/Protease/Amylase | 32 | 37 | Under 11 | $80K |
| Mesalamine Generic | 23 | 57 | Under 11 | $8,759 |
| Esomeprazole Magnesium Generic | 18 | 40 | Under 11 | $564 |
| Ursodiol Generic | 17 | 22 | Under 11 | $666 |
| Spironolactone Generic | 13 | 29 | Under 11 | $256 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 12 | 12 | 12 | $1,676 |
Brand drugs: 411 claims; generic drugs: 2,026 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Svetlana R Mulcahy $633 ($633 in general payments such as food, travel and fees) from 11 companies. The largest payer was Gilead Sciences, Inc. with $135.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $104 |
| Abbvie Inc. ABBV | 5 | $94.7 |
| Genzyme Corporation SNY | 2 | $69.19 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $46.29 |
| Aimmune Therapeutics, Inc. | 2 | $45.6 |
| Janssen Biotech, Inc. JNJ | 2 | $37.18 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $33.85 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $26.17 |
| Novo Nordisk Inc NVO | 1 | $25.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.